Can-Fite to Harness Artificial Intelligence to Develop Novel Anti-Cancer Drugs

Go back to Can-Fite to Harness Artificial Intelligence to Develop Novel Anti-Cancer Drugs
CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 2.24 +0.08 (3.70%)
Previous Close $2.16    52 Week High $3.89 
Open $2.17    52 Week Low $1.85 
Day High $2.28    P/E N/A 
Day Low $2.16    EPS $0.00 
Volume 11,044       

CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 2.24 +0.08 (3.70%)
Previous Close $2.16    52 Week High $3.89 
Open $2.17    52 Week Low $1.85 
Day High $2.28    P/E N/A 
Day Low $2.16    EPS $0.00 
Volume 11,044